Company Overview: Cytori

Industry News

17 Mar

Cytori to Webcast Fourth Quarter Financial Results on March 23rd

SAN DIEGO, March 17, 2017 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (CYTX) will provide a live webcast of its fourth quarter financial results and business update on Thursday, March 23, 2017 at 5:30 PM Eastern Time. The dial-in information is as follows: Dial-In Number: +1.877.402.3914 Conference ID: 90778155 Prior...

Read more

19 Jan

Cytori to Acquire Proprietary Nanoparticle Development Platform to Enhance Regenerative Medicine Leadership Position

SAN DIEGO, Jan. 19, 2017 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (CYTX) (the “Company” or “Cytori”) today announced it has entered into a definitive agreement (the “Purchase Agreement”) to acquire certain assets from privately held Azaya Therapeutics Inc., a leader in the research, development and manufacturing of nanoparticle and...

Read more

29 Dec

Ronald Martell to Join Cytori Therapeutics’ Board of Directors

SAN DIEGO, Dec. 28, 2016 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (CYTX) (“Cytori” or the “Company”) today announced that Ronald A. Martell has joined the Company’s Board of Directors to serve as an independent director, effective December 27, 2016. Mr. Martell has more than 25 years’ experience building and managing unique businesses...

Read more

14 Dec

Cytori Pivotal ADRESU Incontinence Trial Hits 50% Enrollment Milestone

SAN DIEGO, Dec. 14, 2016 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (CYTX) today announced that over half of 45 patients in the ADRESU trial in Japan have been enrolled and treated. ADRESU is a late phase, investigator-initiated Japanese clinical trial to study the efficacy and safety of Cytori Cell...

Read more

29 Nov

Cytori Announces Two Year Follow-Up Published on EU Scleroderma Trial

SAN DIEGO, Nov. 29, 2016 (GLOBE NEWSWIRE) — Cytori Therapeutics, Inc. (CYTX) announced today publication of two-year clinical follow-up of patients treated with a single administration of ECCS-50 in the SCLERADEC-I pilot trial of Cytori Cell Therapy in patients with hand dysfunction associated with scleroderma. The results, published by Dr....

Read more

Page 1 of 512345

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address